Amneal Pharmaceuticals, Inc.

Complete recall history across all FDA and CPSC categories — 10 total recalls

Amneal Pharmaceuticals, Inc. appears in recall records across 1 category. This page consolidates all FDA food, drug, and medical device enforcement actions, plus CPSC consumer product recalls associated with this company. Recall data is sourced from openFDA and CPSC public databases.

Drug Recalls (10)

FDA drug safety enforcement actions by Amneal Pharmaceuticals, Inc.

Date Product Reason Class
Nov 22, 2019 Ranitidine Syrup Oral Solution 15 mg/mL 6. fl. oz. (473 mL), NDC 65162-664-90. CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API Class II
Nov 22, 2019 Ranitidine Tablets, USP 150 mg, 1000-count bottles, NDC 53746-253-10. CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API Class II
Nov 22, 2019 Ranitidine Tablets, USP 150 mg a).60-count bottles (NDC 65162-253-06) , b).1... CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API Class II
Nov 22, 2019 Ranitidine Tablets, USP 300 mg, 250-count bottles, NDC 53746-254-02. CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API Class II
Nov 22, 2019 Ranitidine Tablets, USP 300 mg - a).30-count bottles (NDC 65162-254-30), b).1... CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API Class II
Oct 16, 2019 Isotretinoin Capsules, USP 10 mg. Rx Only, 3 Prescription Blister Packs of 10... Failed Impurities/Degradation Specifications: Tretinoin levels slightly above... Class III
Sep 24, 2019 Benazepril HCl Tablets, USP 40 mg, 100 count bottles, Rx only, Distributed by... Presence of Foreign Tablet/Capsule; Promethazine HCl tablet found in the Bena... Class III
Jul 18, 2019 Methylergonovine Maleate USP 0.2 mg Tablets a) 12 count (NDC 69238-1605-02) ... Presence of Foreign Tablet/Capsule; one Promethazine tablet was found in a bo... Class III
Sep 25, 2017 Esterified Estrogens & Methyltestosterone Tablets, USP 0.625 mg/1.25 mg, 100... Subpotent Drug: Out of specification assay result in Esterified Estrogen and ... Class III
Sep 25, 2017 Esterified Estrogens & Methyltestosterone Tablets, USP 1.25 mg/2.5 mg, 100-c... Subpotent Drug: Out of specification assay result in Esterified Estrogen and ... Class III

Frequently Asked Questions

A high number of recalls does not necessarily indicate that a company is unsafe. Large manufacturers that produce thousands of products across multiple categories will statistically appear in recall databases more frequently. What matters more is the severity of each recall (Class I being the most serious), the speed of response, and whether the company proactively identified and addressed the issue. Companies with robust safety programs often catch problems earlier.

Food, drug, and medical device recall data comes from the FDA's openFDA enforcement database, which contains all FDA enforcement reports. Consumer product recall data comes from the U.S. Consumer Product Safety Commission (CPSC). Both sources are public government databases that are updated regularly. RecallCheck aggregates these sources to provide a unified view of a company's recall history.

The FDA classifies recalls into three categories. Class I is the most serious — there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. Class II means the product may cause temporary or medically reversible health problems, or the probability of serious consequences is remote. Class III is the least serious — the product is unlikely to cause adverse health consequences. CPSC product recalls do not use this classification system.

Yes. You can search for any company using the firm/manufacturer pages for each category: Food Firms, Drug Firms, Device Firms, or Product Manufacturers. You can also use the search functionality on any browse page to find recalls by company name.

Explore More Recalls

Search recalls by category, state, reason, or firm across all our databases.